drug binding

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/6

encourage image

There's no tags or description

Looks like no tags are added yet.

7 Terms

1
New cards

List the five sources/categories of drugs, the five reasons drugs are taken, and the six causes of drug side effects and toxicity.

Drug sources: 1. Natural substances from plants/animals (e.g., tetrodotoxin [TTX], a pufferfish Na+ channel blocker). 2. Synthetic chemicals. 3. Products of biotechnology. 4. Endogenous substances. 5. Inorganic poisons. Reasons taken: cure, symptom suppression, prevention, diagnosis, recreation. Causes of side effects/toxicity: 1. Insufficient selectivity. 2. Target site is widespread and mediates multiple processes. 3. Long-term/permanent structural or functional changes from prolonged use. 4. Incomplete knowledge of disease process. 5. Patient variability. 6. Drug interactions.

2
New cards

Contrast drug naming conventions (chemical, generic, brand) and list the six main molecular target classes for drug action.

A single drug has a chemical name, a generic name (can vary by country, e.g., adrenaline [UK] vs. epinephrine [USA]; isoprenaline [UK] vs. isoproterenol [USA]; diazepam; ibuprofen), and brand names (e.g., Eppy/Simplene, Saventrine, Valium, Nurofen). Molecular targets: 1. Receptors. 2. Enzymes. 3. Transporters. 4. Ion channels. 5. Nucleic acids. 6. Miscellaneous (lipids, metal ions, etc.).

3
New cards

Distinguish between an agonist and an antagonist in terms of receptor binding and activation, and state the chemical properties influencing drug–receptor binding.

Both agonists and antagonists bind to the receptor, but an agonist 'turns on' (activates) the receptor to evoke a cellular response, whereas an antagonist binds and occupies the binding site without activating it, preventing other ligands from acting. Drug–receptor interaction is influenced by chemical structure, molecular size, lipophilicity, and pH/ionisation.

4
New cards

Explain the Law of Mass Action as applied to reversible drug–receptor binding at equilibrium.

The rate of a chemical reaction is proportional to the product of the reactant concentrations: D + R

5
New cards

Define the dissociation equilibrium constant (KD), state its units, and explain its relationship to drug affinity.

KD = k-1 / k+1 = ([D][R]) / [DR] (units: molar, mol/L). KD is the drug concentration that occupies 50% of receptors at equilibrium (where [R] = [DR]). KD and affinity are inversely related: a low KD indicates high affinity (strong binding), while a high KD indicates low affinity (weak binding).

6
New cards

Derive the fractional receptor occupancy equation and state the five assumptions required for it to be strictly valid.

Total receptors [RT] = [DR] + [R], so [R] = [RT] - [DR]. Substituting into KD = ([D][R])/[DR] yields fractional occupancy P = [DR]/[RT] = [D] / ([D] + KD). Five validity conditions: 1. System is at equilibrium. 2. Drug concentration at receptors equals the applied concentration. 3. One drug molecule binds one receptor molecule (1:1 stoichiometry). 4. A negligible fraction of added drug is bound. 5. Binding of one drug molecule does not alter the binding of another (no cooperativity).

7
New cards

Describe the shape of a binding curve on linear versus semi-log axes and explain what determines total receptor number (RT) and curve position.

On a linear [Drug] axis, fractional occupancy P forms a saturable rectangular hyperbola whose y-axis asymptote estimates total receptor number (RT) and whose half-maximal x-value is KD (note: binding curves reveal nothing about biological response). On a semi-log (log10 [Drug]) plot, the curve is sigmoidal; its horizontal position along the concentration axis is governed solely by affinity—higher affinity (lower KD) shifts the curve further to the left.